Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
The Journal of Biochemistry
Year: 2010  |  Volume: 148  |  Issue: 2  |  Page No.: 247 - 254

Distinction of the binding modes for human nuclear receptor ERR{gamma} between bisphenol A and 4-hydroxytamoxifen

X Liu, A Matsushima, H Okada and Y. Shimohigashi    

Abstract:

Bisphenol A (BPA) strongly binds to human estrogen-related receptor (ERR). BPA is an oestrogenic endocrine disruptor that influences various physiological functions at very low doses. BPA functions as an inverse-type antagonist of ERR to retain its high basal constitutive activity by inhibiting the deactivating inverse agonist activity of 4-hydroxytamoxifen (4-OHT). We recently demonstrated that ERR receptor residues Glu275 and Arg316 function as the intrinsic binding site of BPA’s phenol-hydroxyl group. We also determined the chief importance of phenol-hydroxylArg316 hydrogen bonding and the corroborative role of phenol-hydroxylGlu275 hydrogen bonding. However, there appeared to be a distinct difference between the receptor binding modes of BPA and 4-OHT. In the present study, using tritium-labelled or non-labelled BPA and 4-OHT, we evaluated in detail the receptor binding capabilities of wild-type ERR and its mutants with amino acid alterations at positions 275 and 316. Both compounds exhibited a strong binding ability to wild-type ERR due to the hydrogen bonding to Glu275 and Arg316. However, 4-OHT revealed significantly reduced occupancy for both wild-type and mutant receptors. The data obtained suggest that 4-OHT barely binds to ERR due to the strong ability of Glu275 and Arg316 to recruit phenol compounds.

View Fulltext    |   Related Articles   |   Back
   
 
 
 
  Related Articles

No Article Found
 
 
 
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility